Platinum Analytics Cayman (PLTS) appeals Nasdaq delisting move amid trading halt
Rhea-AI Filing Summary
Platinum Analytics Cayman Limited reports that Nasdaq’s Listing Qualifications Department issued a Staff Delisting Determination on July 7, 2026, using its discretionary authority under Nasdaq Listing Rule IM-5101-4 to delist the company’s securities. Trading in the securities is already halted under Rule 4120(a)(5).
The company plans to appeal by requesting an oral hearing before the Nasdaq Hearings Panel under Rule 5815 and will submit a detailed written submission outlining its legal arguments and reasons for review. A hearing request regarding a delinquent filing automatically stays suspension only for 15 days unless the Panel grants a further stay. The company will ask the Panel to find it in compliance with all applicable listing standards but warns there is no assurance the Panel will agree.
Positive
- None.
Negative
- Nasdaq Staff Delisting Determination and trading halt place PLTS’s U.S. listing and near‑term liquidity at risk, with no assurance its appeal will succeed.
Insights
Nasdaq delisting threat raises significant listing and liquidity risk for PLTS.
Platinum Analytics Cayman Limited has received a Nasdaq Staff Delisting Determination under Listing Rule IM-5101-4, and its securities are subject to a trading halt under Rule 4120(a)(5). This directly affects where and how the shares can trade, reducing immediate liquidity and price discovery.
The company will appeal, requesting an oral hearing under Rule 5815 and submitting a written brief with its legal arguments. A hearing request for a delinquent filing only provides an automatic stay of up to 15 days, and any longer stay depends on the Nasdaq Hearings Panel. The company explicitly notes there is no assurance the Panel will find it in compliance, so the outcome and future trading venue remain uncertain.
Key Figures
Key Terms
Staff Delisting Determination regulatory
Nasdaq Listing Rule IM-5101-4 regulatory
trading halt market
Nasdaq Hearings Panel regulatory
FAQ
What did Platinum Analytics Cayman Limited (PLTS) disclose about its Nasdaq listing status?
Is PLTS appealing the Nasdaq Staff Delisting Determination?
How long can PLTS’s Nasdaq suspension be automatically stayed during the appeal process?
Does PLTS guarantee it will remain listed on Nasdaq after the appeal?
What business does Platinum Analytics Cayman Limited (PLTS) operate?
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 2026
Commission File Number: 001-42853
PLATINUM ANALYTICS CAYMAN LIMITED
(Registrant’s Name)
60 Anson Road, 17-01
Mapletree, Singapore 079914
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Nasdaq Delisting Notice And Company Appeal
On July 7, 2026, Platinum Analytics Cayman Limited (the “Company”) received a Staff Delisting Determination (the “Staff Determination”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that Nasdaq has determined to delist the Company’s securities pursuant to its discretionary authority contained in Nasdaq Listing Rule IM-5101-4.
The Company intends to appeal the Staff Determination by filing a request for oral hearing before the Nasdaq Hearings Panel (the “Panel”) pursuant to Nasdaq Listing Rule 5815. Per Rule 5815(a)(1)(B), a request for a hearing regarding a delinquent filing will only stay the suspension of the Company’s securities for a period of 15 days from the deadline to request a hearing unless the Company specifically requests, and the Hearings Panel grants, a further stay. The current trading halt under Rule 4120(a)(5) with regards to the Company’s securities will remain in place during any automatic stay or further stay granted by the Panel.
Per Listing Rule 5815(a)(5), the Company will submit to the Hearings Panel a written submission stating with specificity the grounds on which the Company is seeking review of the Staff Determination notification in accordance with Listing Rule 5815(a) (1) (“Written Submission”), and the Company will include in the Written Submission all legal arguments on which it intends to rely. The Company will request that the Panel find the Company in compliance with all applicable listing standards, pursuant to Rule 5815(c)(1)(E). There can be no assurance, however, that the Panel will find the Company in compliance with all applicable listing standards.
The Company furnishes this report on Form 6-K to satisfy its obligation under Listing Rule 5810(b) to make public disclosure of the subject deficiency and of the Staff Determination within four business days thereof.
Forward-Looking Statements
This Form 6-K contains forward-looking statements that involve risks and uncertainties. The risks and uncertainties involved include the Company’s ability to regain compliance with Nasdaq’s rules for continued listing, market conditions, and other risks detailed from time to time in the Company’s periodic reports and other filings with the U.S. Securities and Exchange Commission. You are cautioned not to place undue reliance on forward-looking statements, which are based on the Company’s current expectations and assumptions and speak only as of the date of this Form 6-K. The Company does not intend to revise or update any forward-looking statement in this Form 6-K as a result of new information, future events or otherwise, except as required by law.
Financial Statements and Exhibits
The following exhibits are being filed herewith:
| Exhibit No. | Description | |
| 99.1 | Press Release |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| PLATINUM ANALYTICS CAYMAN LIMITED | ||
| Date: July 10, 2026 | By: | /s/ Huiyi Zheng |
| Name: | Huiyi Zheng | |
| Title: | Chief Executive Officer | |
Exhibit 99.1
Platinum Analytics Cayman Limited Announces Receipt of Delisting Notice from Nasdaq
Singapore, July 10, 2026 — Platinum Analytics Cayman Limited (the “Company” or “PLTS”), a software developer specializing in the provision of FX trading software development solutions, data analytics solutions and technology development solutions to financial institutions with a strategic focus on serving Asia and other emergent markets, today announced that on July 7, 2026, the Company received a Staff Delisting Determination (the “Staff Determination”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that Nasdaq has determined to delist the Company’s securities pursuant to its discretionary authority contained in Nasdaq Listing Rule IM-5101-4.
The Company intends to appeal the Staff Determination by filing a request for oral hearing before the Nasdaq Hearings Panel (the “Panel”) pursuant to Nasdaq Listing Rule 5815. Per Rule 5815(a)(1)(B), a request for a hearing regarding a delinquent filing will only stay the suspension of the Company’s securities for a period of 15 days from the deadline to request a hearing unless the Company specifically requests, and the Hearings Panel grants, a further stay. The current trading halt under Rule 4120(a)(5) with regards to the Company’s securities will remain in place during any automatic stay or further stay granted by the Panel.
Per Listing Rule 5815(a)(5), the Company will submit to the Hearings Panel a written submission stating with specificity the grounds on which the Company is seeking review of the Staff Determination notification in accordance with Listing Rule 5815(a) (1) (“Written Submission”), and the Company will include in the Written Submission all legal arguments on which it intends to rely. The Company will request that the Panel find the Company in compliance with all applicable listing standards, pursuant to Rule 5815(c)(1)(E). There can be no assurance, however, that the Panel will find the Company in compliance with all applicable listing standards.
About Platinum Analytics Cayman Limited
Established in 2017 in Singapore, Platinum Analytics Cayman Limited, through its wholly-owned Singapore subsidiary, Platinum Analytics Singapore Pte. Ltd., develops FX trading software, data analytics, and technology solutions for financial institutions, focusing on Asia and other emergent markets. Supported by the Monetary Authority of Singapore (MAS), it addresses rapid growth in currency trade volumes, complex cross-border transactions, and emerging market volatility.
The Company operates the Platinum ECN spot FX trading platform for institutional and enterprise clients. Its products – Platinum AI, Platinum ECN, and Platinum Smart Trade – deliver scalable, flexible, AI-driven, low-latency trading and analytics. For more information, please visit: www.platinumanalytics.net.
Forward-Looking Statement
This press release contains forward-looking statements that involve risks and uncertainties. The risks and uncertainties involved include the Company’s ability to regain compliance with Nasdaq’s rules for continued listing, market conditions, and other risks detailed from time to time in the Company’s periodic reports and other filings with the U.S. Securities and Exchange Commission. You are cautioned not to place undue reliance on forward-looking statements, which are based on the Company’s current expectations and assumptions and speak only as of the date of this press release. The Company does not intend to revise or update any forward-looking statement in this press release as a result of new information, future events or otherwise, except as required by law.
For more information, please contact:
International Elite Capital
Annabelle Zhang
Email: management@iecapitalusa.com
646-866-7928